Fineline Cube

Follow:
14778 Articles
Merck KGaA’s Pergoveris Treatment Expands Access to Advanced Reproductive Care in Greater Bay Area
CompanyDrug

Merck KGaA’s Pergoveris Treatment Expands Access to Advanced Reproductive Care in Greater Bay Area

Junshi Biosciences' Ongericimab Wins NMPA Nod for Hypercholesterolemia Treatment
CompanyDrug

Junshi Biosciences’ Ongericimab Wins NMPA Nod for Hypercholesterolemia Treatment

WuXi AppTec Addresses Media Speculation on Potential Sale of WuXi ATU
Company

WuXi AppTec Addresses Media Speculation on Potential Sale of WuXi ATU

Juventas Cell Therapy's CAR-T Therapy Clears for SLE-ITP Study in China
CompanyDrug

Juventas Cell Therapy’s CAR-T Therapy Clears for SLE-ITP Study in China

Sanofi Commences Negotiations with CD&R for Potential Sale of Opella Stake
CompanyDeals

Sanofi Commences Negotiations with CD&R for Potential Sale of Opella Stake

SAMR Proposes Guidelines to Curb Commercial Bribery in Pharmaceutical Industry
Policy / Regulatory

SAMR Proposes Guidelines to Curb Commercial Bribery in Pharmaceutical Industry

JD Healthcare and Genrix Bio Join Forces to Revolutionize Patient Care and Pharmacy Services
CompanyDeals

JD Healthcare and Genrix Bio Join Forces to Revolutionize Patient Care and Pharmacy Services

Guangdong Province Aims for RMB One Trillion in Biopharma Industry Growth by 2027
Policy / Regulatory

Guangdong Province Aims for RMB One Trillion in Biopharma Industry Growth by 2027

Immupeutics Medicine Secures NMPA Approval for Personalized Liver Cancer Immunotherapy IPM001
CompanyDrug

Immupeutics Medicine Secures NMPA Approval for Personalized Liver Cancer Immunotherapy IPM001

Eli Lilly & Co. Partners with Insitro to Leverage AI in Metabolic Disease Drug Development
CompanyDeals

Eli Lilly & Co. Partners with Insitro to Leverage AI in Metabolic Disease Drug Development

Pfizer's Hympavzi Secures FDA Nod, Offering Novel Once-Weekly Treatment for Hemophilia B
CompanyDrug

Pfizer’s Hympavzi Secures FDA Nod, Offering Novel Once-Weekly Treatment for Hemophilia B

Hetero and Gilead Sciences Partner to Expand Access to HIV Treatment in Low-Income Countries
CompanyDeals

Hetero and Gilead Sciences Partner to Expand Access to HIV Treatment in Low-Income Countries